Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gustavo Fernández-Pajarín"'
Autor:
Cristina Nombela Otero, Elvira Andújar, Gustavo Fernández-Pajarín, Ángel Sesar, Isabel Jiménez, Juan Martn-Rodriguez, Pablo Mir
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S462- (2023)
Externí odkaz:
https://doaj.org/article/a2e524d9b4f649649d43626d31c114b6
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 6, Iss , Pp 100129- (2022)
Introduction: Parkinson’s disease (PD) patients usually start treatment with apomorphine infusion (APO) in later stages of advanced PD (aPD). This timing limits the evaluation of its motor efficacy and other potential clinical benefits throughout t
Externí odkaz:
https://doaj.org/article/41e5c739986849a386818c7173df0178
Publikováno v:
Revista Mexicana de Neurociencia, Vol 22, Iss 4 (2021)
Identifying the advanced stage in Parkinson’s disease (PD) is crucial for shifting from conventional to device-aided therapies. The criteria to define the onset of advanced PD have been based on lengthy and disabling daily off-times, troublesome dy
Externí odkaz:
https://doaj.org/article/bbf4631430424bc998d08bfc4ee99e9b
Autor:
Gustavo Fernández-Pajarín, Ángel Sesar, José Luis Relova, Begoña Ares, Isabel Jiménez, Miguel Gelabert-González, Eduardo Arán, Alfonso Castro
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 1001 (2022)
Background: The relationship between axial symptoms in Parkinson’s disease (PD) and subthalamic deep brain stimulation (STN-DBS) is still unclear. Purpose: We searched for particular clinical characteristics before STN-DBS linked to on-state axial
Externí odkaz:
https://doaj.org/article/5d7a234da12442daa2497927ff384138
Autor:
José Luis Relova, Ángel Sesar, A. Castro, Miguel Gelabert, Eduardo Arán-Echabe, Gustavo Fernández-Pajarín, Isabel Jiménez-Martín, Begoña Ares
Publikováno v:
Movement Disorders Clinical Practice
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Background: Background Studies comparing the clinical efficacy of apomorphine infusion (APO) with subsequent subthalamic deep brain stimulation (STN-DBS) in advanced Parkinson’s disease (aPD) are currently lacking. Retrospective data have shown tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464b6ddbebd7dad9c969679cf726d9e7
https://doi.org/10.1002/mdc3.13338
https://doi.org/10.1002/mdc3.13338
Publikováno v:
Clinical Parkinsonism & Related Disorders
Clinical Parkinsonism & Related Disorders, Vol 6, Iss, Pp 100129-(2022)
Clinical Parkinsonism & Related Disorders, Vol 6, Iss, Pp 100129-(2022)
Highlights • A prospective analysis of APO treatment of 22 PD patients in the initial stages of advanced PD. • Motor and non-motor symptoms, cognitive function and quality of life were assessed over 6 months. • APO resulted in significant impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d6c67c561cf1a56f81d5ba1651c5c90
http://europepmc.org/articles/PMC8718975
http://europepmc.org/articles/PMC8718975
Publikováno v:
Revista Mexicana de Neurociencia, Vol 22, Iss 4 (2021)
Identifying the advanced stage in Parkinson’s disease (PD) is crucial for shifting from conventional to device-aided therapies. The criteria to define the onset of advanced PD have been based on lengthy and disabling daily off-times, troublesome dy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93209d25eb1d250db62167af9dff85f7
https://www.revmexneurociencia.com/frame_esp.php?id=139
https://www.revmexneurociencia.com/frame_esp.php?id=139
Autor:
José Luis Relova, Begoña Ares, Ángel Sesar, Eduardo Arán, Miguel Gelabert-González, A. Castro, Gustavo Fernández-Pajarín, María-Teresa Rivas
Publikováno v:
Journal of Neurology. 266:659-666
Deep brain stimulation (DBS) is an effective therapy for patients with advanced Parkinson’s disease (PD). However, sometimes, it is not sufficient to adequately control motor symptoms. We describe our experience with continuous subcutaneous apomorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbe5839f50221750179877a02aab0dfd
https://doi.org/10.1007/s00415-019-09184-5
https://doi.org/10.1007/s00415-019-09184-5
Publikováno v:
Neurología.
Resumen Introduccion Las mutaciones en el gen LRRK2 se han relacionado tradicionalmente con un fenotipo benigno de la enfermedad de Parkinson (EP). En la fase avanzada, se ha descrito una respuesta favorable a la estimulacion cerebral profunda (ECP).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be6eb8403aeedd6a263fa053788fa2a3
https://doi.org/10.1016/j.nrl.2020.06.020
https://doi.org/10.1016/j.nrl.2020.06.020
Autor:
Diego Santos García, Gustavo Fernández Pajarín, Juan Manuel Oropesa-Ruiz, Francisco Escamilla Sevilla, Raúl Rashid Abdul Rahim López, José Guillermo Muñoz Enríquez
Publikováno v:
Brain Sciences; Volume 12; Issue 3; Pages: 383
Patients with Parkinson’s disease (PD) can improve some non-motor symptoms (NMS) after starting treatment with opicapone. The aim of this study was to analyze the effectiveness of opicapone on global NMS burden in PD. OPEN-PD (Opicapone Effectivene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c2d598bd400bd521e74e9475a3f32e
https://doi.org/10.3390/brainsci12030383
https://doi.org/10.3390/brainsci12030383